The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) B.Y. Lee, A. Singh, M.Z. David, S.M. Bartsch, R.B. Slayton, S.S. Huang, S.M. Zimmer, M.A. Potter, C.M. Macal, D.S. Lauderdale, L.G. Miller, R.S. Daum Clinical Microbiology and Infection Volume 19, Issue 6, Pages 528-536 (June 2013) DOI: 10.1111/j.1469-0691.2012.03914.x Copyright © 2013 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 1 General structure of the decision model. Clinical Microbiology and Infection 2013 19, 528-536DOI: (10.1111/j.1469-0691.2012.03914.x) Copyright © 2013 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions
Fig. 2 (a) Median cost per SSTI case by age and hospitalization rate assuming only 30% of SSTI patients seek medical care. (b) Median cost per SSTI case (23 years old) by hospitalization rate and probability of patients seeking care. Clinical Microbiology and Infection 2013 19, 528-536DOI: (10.1111/j.1469-0691.2012.03914.x) Copyright © 2013 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions